James Lind pioneered the first clinical trial in the 18th century, using oranges and lemons as a cure for scurvy. Like Lind, ๐จ๐ฎ๐ซ ๐ฆ๐ข๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ฌ ๐ญ๐จ ๐ข๐ฆ๐ฉ๐ซ๐จ๐ฏ๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐จ๐ฎ๐ญ๐๐จ๐ฆ๐๐ฌ ๐๐จ๐ซ ๐๐ฅ๐ฅ.
The cost of bringing new medicines to market has skyrocketed and as a result patients are missing out on new treatments. ๐๐ข๐ง๐๐ฎ๐ฌ ๐๐๐๐ฅ๐ญ๐ก ๐ฐ๐ข๐ฅ๐ฅ ๐๐ข๐ฑ ๐ญ๐ก๐ข๐ฌ.
We're building the platform for the next generation of clinical trials. ๐ ๐ซ๐จ๐ฆ ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฌ๐ข๐ ๐ง ๐ญ๐จ ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ, ๐ฐ๐ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ฉ๐๐ซ๐ญ๐ง๐๐ซ ๐ฐ๐ข๐ญ๐ก ๐ฒ๐จ๐ฎ.
The cost of bringing new medicines to market has skyrocketed and as a result patients are missing out on new treatments. ๐๐ข๐ง๐๐ฎ๐ฌ ๐๐๐๐ฅ๐ญ๐ก ๐ฐ๐ข๐ฅ๐ฅ ๐๐ข๐ฑ ๐ญ๐ก๐ข๐ฌ.
We're building the platform for the next generation of clinical trials. ๐ ๐ซ๐จ๐ฆ ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฌ๐ข๐ ๐ง ๐ญ๐จ ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ, ๐ฐ๐ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ฉ๐๐ซ๐ญ๐ง๐๐ซ ๐ฐ๐ข๐ญ๐ก ๐ฒ๐จ๐ฎ.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $78M
Founders name: Meri Beckwith; Michael Young
Founders Related Locations: United States; United Kingdom, England, London; United Kingdom, England, Oxford
Investors 2
| Date | Name | Website |
| - | Calm/Storm... | calmstorm.... |
| 13.10.2021 | Firstminut... | firstminut... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.02.2025 | Series B | $55M | - |
| 17.08.2023 | Series A | $18M | - |
| 05.11.2021 | Seed | $5M | - |
Persons 2
| Date | First Name | Last Name | Title | Location | |||
| - | Michael | Young | Co-Founder | linkedin.c... | - | - | United Kin... |
| - | Meri | Beckwith | Co-Founder | linkedin.c... | - | - | United Sta... |
Mentions in press and media 26
| Date | Title | Description |
| 16.09.2025 | Half of Consumers Will Abandon Health Products Lacking Clear Scientific Evidence, Survey Reveals | What You Should Know: A new survey by Lindus Health, a clinical trial company, has reveals that transparency about side effects and long-term safety are the top factors Americans consider when buying health products. โ The survey, which ask... |
| 03.02.2025 | Lindus Health: โAnti-CROโ Company Raises $55 Million (Series B) | Lindus Health, an the anti-CRO running faster and more reliable clinical trials, announced it has raised $55 million in Series B funding. This funding round was led by new investor Balderton Capital, with support from Visionaries Club and e... |
| 24.01.2025 | Lindus Health: Revolutionizing Clinical Trials with $55 Million in New Funding | In the world of clinical trials, time is money. Lindus Health, a New York City-based company, has just secured $55 million in Series B funding to reshape this landscape. This infusion of capital, led by Balderton Capital, aims to accelerate... |
| 24.01.2025 | The Weekโs Biggest Funding Rounds: Anthropic Leads Slow, Slow Week | 2 Shares Email Facebook Twitter LinkedIn Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a w... |
| 23.01.2025 | Lindus Health: $55 Million (Series B) Closed For Changing Clinical Trial Landscape | Lindus Health, which is the anti-CRO running faster and more reliable clinical trials, announced it raised $55 million in Series B funding. The funding round was led by new investor Balderton Capital, with support from Visionaries Club and ... |
| 23.01.2025 | Lindus Health secures $55M to advance AI technology for clinical trials | Photo: www.nazphotos.com/Getty Image Lindus Health, a company that conducts end-to-end clinical trials for the life sciences sector, announced it raised $55 million in Series B Funding. The round was led by Balderton Capital with participat... |
| 22.01.2025 | Lindus Health closes fruitful $55M series B to develop clinical trial tech platform | Following last yearโs launches of several all-in-one CRO offerings, Lindus Health is starting 2025 strong by closing a $55 million series B fundraising round. New investor Balderton Capital led the round, with participation from Visionaries... |
| 22.01.2025 | Lindus Health Raises $55M in Series B Funding | Co-Founders Michael Young, Nik Haldimann, and Meri Beckwith. Lindus Health, a NYC-based company that enables customers to run clinical trials, raised $55M in Series B funding. The round was led by new investor Balderton Capital, with suppor... |
| 22.01.2025 | Lindus Health Raises $55M to Accelerate AI-Driven Clinical Trials | What You Should Know: โ Lindus Health, a company transforming the clinical trial landscape with its tech-first approach raises $55M in Series B funding round led by Balderton Capital, with participation from Visionaries Club and existing in... |
| 29.10.2024 | Lindus Health Launches โAll-in-One Womenโs Health CROโ to Accelerate Clinical Trials | What You Should Know: โ Lindus Health, a leading innovator in clinical trial solutions, has announced the launch of its โAll-in-One Womenโs Health CROโ offering. โ The comprehensive suite of services and technology is specifically designed ... |
Show more